ONCY (STOCKS)
Oncolytics Biotech, Inc. Common Shares
$1.080000
+0.060000 (+5.88%)
Prev close: $1.020000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jared Kelly
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $126.58M
- Employees
- 28
- P/E (TTM)
- -4.53
- P/B (TTM)
- -29.00
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.14 | $-0.10 | -0.0425 | -43.53% |
|
Jun 2025 (Q2)
|
$-0.07 | $-0.11 | +0.0377 | +35.00% |
|
Mar 2025 (Q1)
|
$-0.08 | $-0.10 | +0.0210 | +20.79% |
|
Dec 2024 (Q4)
|
$-0.10 | $-0.12 | +0.0231 | +18.77% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $28.73M |
| Research and Development | $13.31M |
| Other Operating Expenses | $15.41M |
| Operating Income/Loss | -$28.73M |
| Income/Loss From Continuing Operations After Tax | -$28.76M |
| Income/Loss From Continuing Operations Before Tax | -$28.68M |
| Income Tax Expense/Benefit | $79.00K |
| Income Tax Expense/Benefit, Current | $79.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$28.76M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$28.76M |
| Net Income/Loss Available To Common Stockholders, Basic | -$28.76M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.30 |
| Diluted Earnings Per Share | -$0.30 |
| Basic Average Shares | 95,857,147 |
| Diluted Average Shares | 95,857,147 |
| Assets | $7.58M |
| Current Assets | $6.84M |
| Prepaid Expenses | $1.07M |
| Other Current Assets | $5.78M |
| Noncurrent Assets | $738.00K |
| Fixed Assets | $228.00K |
| Other Non-current Assets | $510.00K |
| Liabilities | $11.38M |
| Current Liabilities | $6.10M |
| Accounts Payable | $3.50M |
| Other Current Liabilities | $2.60M |
| Noncurrent Liabilities | $5.28M |
| Equity | -$3.80M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$3.80M |
| Liabilities And Equity | $7.58M |
| Net Cash Flow From Operating Activities | -$20.11M |
| Net Cash Flow From Operating Activities, Continuing | -$20.11M |
| Net Cash Flow From Investing Activities | -$6.00K |
| Net Cash Flow From Investing Activities, Continuing | -$6.00K |
| Net Cash Flow From Financing Activities | $14.12M |
| Net Cash Flow From Financing Activities, Continuing | $14.12M |
| Exchange Gains/Losses | $121.00K |
| Net Cash Flow | -$5.88M |
| Net Cash Flow, Continuing | -$6.00M |
| Comprehensive Income/Loss | -$28.90M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$28.90M |
| Other Comprehensive Income/Loss | -$28.90M |